Amcasertib - BBI503

Based on 2 reference(s) in Google Scholar 8 10 2

Axon 2971

CAS [1129403-56-0]

MF C31H33N5O2S
MW 539.69

  • Purity: 98%
  • Soluble in DMSO



Amcasertib is a first-in-class cancer stemness kinase inhibitor with potent in vitro and in vivo activity against cancer stem cells (CSC). By targeting multiple serine-threonine stemness kinases, amcasertib inhibits Nanog and other cancer stemness pathways.

KEYWORDS: Amcasertib | supplier | Stemness kinase inhibitor | BBI503 | BBI-503 | BBI 503 | CAS [1129403-56-0] | Non Selective (Phosphorylation Substrates) | Stemness | Inhibitor | Enzymes | Nanog

Size Unit Price Stock
5 mg €145.00 In Stock
25 mg €445.00 In Stock
Special Offers
Size Unit Price Stock
2 x 5 mg €220.00 In Stock
2 x 25 mg €720.00 In Stock
Need more? Bulk Inquiry

The purity of Axon Ligands™ is confirmed by HPLC-MS, 1H-NMR and/or microanalysis. Analytical data are available upon request.

Caution: Axon Ligands™ are not fully tested. They are for research purposes only! Not for human consumption!

Please wait...